The New Amgen CEO and the Challenges He Faces, Must Win Investors With Payouts, Deals: Analysts

Bob Bradway hasn't even taken the helm at Amgen Inc (AMGN.O), but the clock is already ticking on how the world's largest biotech will compete with rivals, including Big Pharma.
Read the full story: BioSpace.com Featured News